HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Röcken Selected Research

Mitogen-Activated Protein Kinases

10/2020Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic Tumors.
9/2010Activation of the mitogen-activated protein kinase pathway in malignant melanoma can occur independently of the BRAF T1799A mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Röcken Research Topics

Disease

58Neoplasms (Cancer)
01/2024 - 01/2005
19Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019 - 01/2003
18Melanoma (Melanoma, Malignant)
07/2023 - 07/2008
17Inflammation (Inflammations)
01/2021 - 07/2003
17Autoimmune Diseases (Autoimmune Disease)
10/2019 - 01/2003
10Lymphoma (Lymphomas)
10/2021 - 07/2005
10Hypersensitivity (Allergy)
01/2021 - 01/2005
9Neoplasm Metastasis (Metastasis)
01/2024 - 06/2010
8B-Cell Lymphoma (Lymphoma, B Cell)
10/2021 - 05/2014
6Carcinoma (Carcinomatosis)
01/2021 - 06/2008
6Skin Diseases (Skin Disease)
09/2017 - 01/2002
6Infections
11/2014 - 05/2002
5Atopic Dermatitis (Atopic Eczema)
09/2017 - 01/2005
5Dermatitis
01/2016 - 11/2005
4Contact Dermatitis (Eczema, Contact)
01/2019 - 10/2002
4Hypoxia (Hypoxemia)
01/2017 - 03/2008
3Acidosis
12/2023 - 05/2012
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2023 - 01/2007
3Pemphigus (Pemphigus Vulgaris)
10/2019 - 04/2005
3Multiple Sclerosis
10/2011 - 06/2004
3Carcinogenesis
06/2008 - 01/2004
2Encephalomyelitis (Myeloencephalitis)
01/2018 - 01/2017
2Rheumatoid Arthritis
01/2017 - 06/2004
2Bullous Pemphigoid (Pemphigoid)
12/2015 - 07/2012
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/2015 - 10/2011
2Necrosis
02/2013 - 06/2009
2Arthritis (Polyarthritis)
05/2012 - 06/2007
2Vitiligo
11/2005 - 01/2005

Drug/Important Bio-Agent (IBA)

23CytokinesIBA
08/2022 - 07/2002
14AntigensIBA
01/2022 - 06/2004
12Immune Checkpoint InhibitorsIBA
12/2023 - 10/2019
9AntibodiesIBA
01/2022 - 05/2002
9Interleukin-12 (IL 12)IBA
05/2021 - 11/2007
9Interleukin-4 (Interleukin 4)IBA
02/2015 - 05/2002
8Interferon-gamma (Interferon, gamma)IBA
12/2023 - 01/2003
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 11/2007
5Biomarkers (Surrogate Marker)IBA
12/2023 - 11/2011
5Peptides (Polypeptides)IBA
05/2021 - 01/2005
4Neoplasm Antigens (Tumor Antigens)IBA
01/2023 - 10/2008
4Oxygen (Dioxygen)IBA
01/2023 - 11/2011
4VaccinesIBA
01/2022 - 08/2003
4AutoantigensIBA
01/2022 - 07/2003
4Interleukin-10 (Interleukin 10)IBA
10/2021 - 05/2014
4Therapeutic UsesIBA
05/2021 - 03/2008
4Interleukin-8 (Interleukin 8)IBA
01/2021 - 01/2003
4InterferonsIBA
12/2020 - 04/2012
4Dimethyl FumarateIBA
01/2018 - 08/2007
4LigandsIBA
09/2015 - 07/2005
4Interleukin-23 (Interleukin 23)IBA
02/2015 - 11/2007
4FumaratesIBA
10/2011 - 06/2004
3Proteins (Proteins, Gene)FDA Link
01/2023 - 07/2015
3AutoantibodiesIBA
01/2023 - 06/2007
3DNA (Deoxyribonucleic Acid)IBA
10/2020 - 09/2010
3OvalbuminIBA
01/2017 - 01/2015
3Interleukin-17 (Interleukin 17)IBA
09/2015 - 11/2007
3Type I Tumor Necrosis Factor ReceptorsIBA
02/2013 - 06/2008
2Messenger RNA (mRNA)IBA
12/2023 - 06/2006
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2023 - 01/2021
2EnzymesIBA
01/2023 - 01/2007
2RNA (Ribonucleic Acid)IBA
01/2022 - 12/2018
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 01/2017
2NitrogenIBA
01/2021 - 01/2020
2InterleukinsIBA
01/2021 - 06/2009
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 10/2020
2Programmed Cell Death 1 ReceptorIBA
01/2021 - 11/2018
2Mitogen-Activated Protein KinasesIBA
10/2020 - 09/2010
2CTLA-4 AntigenIBA
10/2019 - 11/2018
2Dicyclohexylcarbodiimide (DCCD)IBA
01/2018 - 02/2014
2AllergensIBA
09/2017 - 01/2014
2fluoroazomycin arabinosideIBA
01/2017 - 11/2011
2Lactic Acid (Lactate)FDA LinkGeneric
01/2017 - 05/2012
2Toll-Like Receptor 2IBA
01/2016 - 07/2014
2Matrix Metalloproteinases (MMPs)IBA
12/2015 - 01/2014
2CholesterolIBA
09/2015 - 02/2014
2Interleukin-2 (IL2)IBA
07/2015 - 06/2006
2Interleukin-6 (Interleukin 6)IBA
11/2014 - 12/2011
2Isotretinoin (Accutane)FDA LinkGeneric
05/2012 - 11/2008
2ChemokinesIBA
04/2012 - 06/2008
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2012 - 05/2008
2Imatinib Mesylate (Gleevec)FDA Link
07/2011 - 09/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009 - 03/2008
2AngiopoietinsIBA
06/2009 - 03/2008
2Integrin beta3 (GPIIIa)IBA
06/2008 - 01/2005
2Mitochondrial DNA (mtDNA)IBA
02/2007 - 12/2006
2Thalidomide (Thalomid)FDA Link
01/2007 - 02/2003
2Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2006 - 01/2005
2HaptensIBA
01/2005 - 10/2002
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2024
1Insulin (Novolin)FDA Link
01/2024
1Sodium Bicarbonate (Baking Soda)FDA LinkGeneric
12/2023
1B7-H1 AntigenIBA
12/2023
1STAT1 Transcription FactorIBA
12/2023

Therapy/Procedure

36Therapeutics
01/2024 - 01/2003
15Immunotherapy
12/2023 - 02/2014
5Phototherapy (Light Therapy)
08/2016 - 01/2002
3Radiotherapy
11/2023 - 10/2014
3Lasers (Laser)
09/2010 - 02/2007
3Photochemotherapy (Photodynamic Therapy)
11/2009 - 01/2004
2Transplantation
01/2018 - 05/2007
1Ketogenic Diet
01/2024